Phase 2 Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You fully understand the study, agree to take part voluntarily, and are willing to sign a consent form.
- You are a woman between 18 and 75 years old (inclusive).
- Your doctor estimates you are expected to live for at least 3 months or more.
- Your cancer has been confirmed by a tissue sample (biopsy) to be squamous cell carcinoma of the cervix, vagina, or vulva.
- You have already received at least one standard treatment that included both a platinum-based chemotherapy and an immunotherapy drug, and you have had no more than 4 previous lines of treatment in total.
- You are generally well enough to carry out light daily activities, with little or no limitation (this is measured on a standard scale called ECOG — confirm with trial site if unsure of your score).
- You have at least one area of cancer that can be measured on a scan, according to standard measurement guidelines.
- Your blood counts are within acceptable ranges, meaning your bone marrow is producing enough blood cells (confirm specific values with trial site).
- Your liver and kidney function blood test results are within acceptable ranges (confirm specific values with trial site).
- You are not pregnant or breastfeeding, and if you could become pregnant, you have had a negative pregnancy blood test within 28 days before joining and agree to use effective contraception from signing the consent form until 6 months after your last dose of the study drug.
- You agree to provide blood and tissue samples for the study.
Who may not be able to join:
- You have a known allergy or serious reaction to any of the study drugs or their ingredients.
- You have taken certain medications that strongly interact with the study drug — including some epilepsy medicines (such as phenytoin, phenobarbital, or carbamazepine), rifampicin, rifabutin, or St. John's Wort in the past 2 weeks; or certain antibiotics, antifungals, or HIV medicines, or consumed grapefruit juice in the past week (confirm full list with trial site).
- Your cancer has spread to the brain, spinal cord, or the lining around the brain or spinal cord.
- You have an uncontrolled ongoing illness (such as a serious infection, uncontrolled high blood pressure, or uncontrolled diabetes), or a mental health or personal situation that would make it difficult to follow the study requirements.
- You have a confirmed bowel blockage on a scan, or a history of inflammatory bowel disease, Crohn's disease, ulcerative colitis, or major bowel surgery that caused long-term diarrhoea.
- You have an active hepatitis B or hepatitis C infection with detectable virus levels in your blood (confirm specific levels with trial site).
- You have HIV infection (confirmed by a positive HIV antibody test).
- You have had major surgery or a serious injury within the 30 days before starting the study, or have major surgery planned within 30 days after starting.
- You are pregnant, breastfeeding, or could become pregnant and are unwilling to use effective contraception.
- Your doctor considers there to be any other reason you would not be suitable for this study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Guiling Li, Doctor, Union Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China
Phone: 027-83262598
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The objective response rate of the treatment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.